Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Narrative) (Details)

v3.21.1
Subsequent Events (Narrative) (Details) - USD ($)
$ in Millions
May 13, 2021
Feb. 24, 2021
Sentynl Therapeutics, Inc [Member] | Cyprium [Member]    
Subsequent Event [Line Items]    
Payment of Upfront Fees   $ 8.0
Payments of Milestone   $ 12.0
Subsequent Events [Member] | Demira, Inc [Member] | Journey [Member]    
Subsequent Event [Line Items]    
Payment of Upfront Fees $ 12.5  
Payments of Milestone $ 144.0  
Percentage of royalty amounts diminution in the event of loss of exclusivity 50.00%